drug development

Pharmacogenetics guides better psychiatric drug treatments.

There are currently no FDA-approved drugs to treat vitiligo, an autoimmune disease that kills skin pigment cells. But a phase III study of a drug used to treat atopic dermatitis may be the first to get the FDA seal of approval.

COVID-19 researchers focus their studies on antibodies targeting exposed parts of SARS-CoV-2, but in a new study, a group of researchers showed that antibodies targeting proteins inside the virus are just as important for a robust immune response.

Some scientists use cancer patients as libraries for discovering novel immunotherapies.

Join a panel of experts as they discuss nanoparticle technology and key considerations for nanoparticle-based drug delivery.  

An obesity medicine clinician researcher propels a growing movement to normalize obesity as a disease that requires long-term treatment.

Silicon nanoneedles loaded with ocular drugs hold potential to replace invasive injections to the eye.

It’s human nature to compare one’s success to others, but thinking that the grass is greener on the other side can be detrimental to one’s health. Recognizing strategies as equal but unique ways to tackle a common problem is a healthier perspective.

Membraneless droplet like organelles known as condensates are changing the way some scientists approach drug discovery.

Researchers no longer think that proteins blindly swim through the cytoplasm hoping to bump into one another. Instead, they intentionally aggregate with other biomolecules, forming membrane free, transient organelles called condensates.